We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
301
NVIDIA
NVDA
$5.01T
$9.27M 0.07%
976,000
-72,000
-7% -$583K
ADI icon
302
Analog Devices
ADI
$176B
$9.23M 0.07%
75,300
LGF.A
303
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$9.19M 0.07%
1,240,117
-829,938
-40% -$6.15M
OLED icon
304
Universal Display
OLED
$3.67B
$9.11M 0.07%
60,868
+68
+0.1% +$9.98K
ODT
305
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$9.05M 0.07%
213,770
-246,198
-54% -$7.97M
AGCO icon
306
AGCO
AGCO
$7.28B
$8.85M 0.07%
159,650
-29,150
-15% -$1.52M
WTM icon
307
White Mountains Insurance
WTM
$5.2B
$8.57M 0.07%
9,650
-1,775
-16% -$1.6M
BAP icon
308
Credicorp
BAP
$31.4B
$8.57M 0.07%
64,093
+7,310
+13% +$1.04M
UHS icon
309
Universal Health Services
UHS
$10.2B
$8.42M 0.06%
+90,600
New +$9.06M
COST icon
310
Costco
COST
$423B
$8.4M 0.06%
27,700
-2,000
-7% -$608K
LAMR icon
311
Lamar Advertising Co
LAMR
$16B
$8.39M 0.06%
125,725
-63,400
-34% -$3.87M
AMT icon
312
American Tower
AMT
$80.6B
$8.3M 0.06%
32,100
-2,300
-7% -$569K
ON icon
313
ON Semiconductor
ON
$31.3B
$8.17M 0.06%
412,175
+266,975
+184% +$4.35M
HUM icon
314
Humana
HUM
$45B
$8.09M 0.06%
20,870
-46,881
-69% -$17.5M
TMO icon
315
Thermo Fisher Scientific
TMO
$213B
$7.9M 0.06%
21,800
-1,400
-6% -$469K
ACGL icon
316
Arch Capital
ACGL
$34.5B
$7.87M 0.06%
274,825
-149,025
-35% -$4.12M
ZS icon
317
Zscaler
ZS
$25B
$7.8M 0.06%
71,275
-62,600
-47% -$5.2M
RDS.B
318
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$7.8M 0.06%
256,195
+98,519
+62% +$3.22M
TSN icon
319
Tyson Foods
TSN
$21B
$7.69M 0.06%
128,807
-175,425
-58% -$10.6M
SAP icon
320
SAP
SAP
$219B
$7.68M 0.06%
54,829
-9,871
-15% -$1.22M
MTD icon
321
Mettler-Toledo International
MTD
$29.2B
$7.67M 0.06%
9,526
-3,149
-25% -$2.34M
NVS icon
322
Novartis
NVS
$292B
$7.66M 0.06%
87,733
+603
+0.7% +$52.1K
NVO
323
Novo Nordisk
NVO
$208B
$7.54M 0.06%
230,448
-116,682
-34% -$3.72M
BKI
324
DELISTED
Black Knight, Inc. Common Stock
BKI
$7.54M 0.06%
103,900
-94,925
-48% -$6.73M
DAL icon
325
Delta Air Lines
DAL
$60.2B
$7.51M 0.06%
267,925
+131,475
+96% +$3.34M

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.